Related references
Note: Only part of the references are listed.Machine intelligence in non-invasive endocrine cancer diagnostics
Nicole M. Thomasian et al.
NATURE REVIEWS ENDOCRINOLOGY (2022)
Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome
Lukas Andereggen et al.
JOURNAL OF NEURORADIOLOGY (2021)
Radiomics With Ensemble Machine Learning Predicts Dopamine Agonist Response in Patients With Prolactinoma
Yae Won Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma
Ingrid M. Zandbergen et al.
TRIALS (2021)
Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas
Lukas Andereggen et al.
SCIENTIFIC REPORTS (2021)
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction
Rohan Khera et al.
JAMA CARDIOLOGY (2021)
Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort
Lukas Andereggen et al.
ACTA NEUROCHIRURGICA (2021)
Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study
Yi Fang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
GAMER-MRI in Multiple Sclerosis Identifies the Diffusion-Based Microstructural Measures That Are Most Sensitive to Focal Damage: A Deep-Learning-Based Analysis and Clinico-Biological Validation
Po-Jui Lu et al.
FRONTIERS IN NEUROSCIENCE (2021)
First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center
L. Andereggen et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Commentary: Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery
Lukas Andereggen et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
Pier Paolo Mattogno et al.
CANCERS (2021)
Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term
Lukas Andereggen et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2021)
Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated
Lukas Andereggen et al.
ENDOCRINE (2021)
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
Amir H. Zamanipoor Najafabadi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation
Davide Chicco et al.
BMC GENOMICS (2020)
Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery
Grzegorz Zielinski et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Logistic regression was as good as machine learning for predicting major chronic diseases
Simon Nusinovici et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
Jose Miguel Hinojosa-Amaya et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Machine Learning in Medicine
Alvin Rajkomar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
Evangelia Christodoulou et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
A ten-year follow-up study of treatment outcome of craniopharyngiomas
SWISS MEDICAL WEEKLY (2018)
Validation in prediction research: the waste by data splitting COMMENTARY
Ewout W. Steyerberg
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
Qianquan Ma et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis
Miao Yun Xia et al.
ENDOCRINE (2018)
Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal
Margarida Teixeira et al.
PITUITARY (2017)
Optimal classifier for imbalanced data using Matthews Correlation Coefficient metric
Sabri Boughorbel et al.
PLOS ONE (2017)
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
M. Beatriz S. Lopes
ACTA NEUROPATHOLOGICA (2017)
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP
Diane Donegan et al.
ENDOCRINE PRACTICE (2017)
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas
Lukas Andereggen et al.
ENDOCRINE (2017)
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
Sema Ciftci Dogansen et al.
PITUITARY (2016)
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas
E. Sala et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
Alexander S. G. Micko et al.
JOURNAL OF NEUROSURGERY (2015)
Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis
Jintao Hu et al.
PITUITARY (2015)
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience
A. Arduc et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study
Irina Bancos et al.
CLINICAL ENDOCRINOLOGY (2014)
Second attempt to withdraw cabergoline in prolactinomas: a pilot study
Ratchaneewan Kwancharoen et al.
PITUITARY (2014)
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss et al.
JAMA INTERNAL MEDICINE (2014)
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore et al.
JAMA INTERNAL MEDICINE (2014)
Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients
Vanessa Primeau et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Olaf M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma
Neil Herring et al.
CLINICAL ENDOCRINOLOGY (2009)
Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactinemia
M. Kars et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion
Zhe Bao Wu et al.
PITUITARY (2008)
Super learner
Mark J. van der Laan et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2007)
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy
Annamaria Colao et al.
CLINICAL ENDOCRINOLOGY (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma
Niki Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2006)
Pituitary disease: Presentation, diagnosis, and management
A Levy
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia
A Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)